InvestorsObserver
×
News Home

Should You Add aTyr Pharma Inc (LIFE) Stock to Your Portfolio Friday?

Friday, March 15, 2024 01:53 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Add aTyr Pharma Inc (LIFE) Stock to Your Portfolio Friday?

A rating of 75 puts aTyr Pharma Inc (LIFE) near the top of the Healthcare sector according to InvestorsObserver. aTyr Pharma Inc's score of 75 means that it ranks higher than 75% of stocks in the sector. In addition, its overall score of 45 ranks it higher than 45% of all stocks.

Overall Score - 45
LIFE has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on LIFE!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 45 would rank higher than 45 percent of all stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With aTyr Pharma Inc Stock Today?

aTyr Pharma Inc (LIFE) stock is higher by 19.13% while the S&P 500 is down -0.75% as of 1:52 PM on Friday, Mar 15. LIFE is up $0.31 from the previous closing price of $1.62 on volume of 944,176 shares. Over the past year the S&P 500 is higher by 29.08% while LIFE is up 1.05%. LIFE lost -$0.94 per share the over the last 12 months. Click Here to get the full Stock Report for aTyr Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App